REED JOHN C
SEC insider (Form 3/4/5 filer). CIK 0001181561. Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL) and 1 other issuer. 25 reported Form 4/5 transactions since Sep 2024; latest on Aug 15, 2026. Located in WEST CONSHOHOCKEN, PA.
Companies REED JOHN C has filed insider reports for
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Director
- JOHNSON & JOHNSON (JNJ): Officer, EVP, Innovative Medicine, R&D
REED JOHN C
CIK: 0001181561
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Aug 15, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
AwardDirect647 shares- - May 1, 2026JNJ
JOHNSON & JOHNSON
Tax PaymentDirect11K shares at avg. $229.85$2.5M - May 1, 2026JNJ
JOHNSON & JOHNSON
ExerciseDirect25.3K shares- - Feb 17, 2026JNJ
JOHNSON & JOHNSON
SaleDirect21.7K shares at avg. $243.00$5.3M - Feb 17, 2026JNJ
JOHNSON & JOHNSON
ExerciseDirect21.7K shares at avg. $157.92$3.4M - Feb 17, 2026JNJ
JOHNSON & JOHNSON
ExerciseDirect29.9K shares at avg. $156.15$4.7M - Feb 17, 2026JNJ
JOHNSON & JOHNSON
SaleDirect2.3K shares at avg. $243.00$555K - Feb 17, 2026JNJ
JOHNSON & JOHNSON
SaleDirect29.9K shares at avg. $243.00$7.3M - Feb 15, 2026JNJ
JOHNSON & JOHNSON
ExerciseDirect1.8K shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Tax PaymentDirect385 shares at avg. $243.45$94K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 15, 2026 |  MDGL MADRIGAL PHARMACEUTICALS, INC. | Award | 647 | - | $0 | Direct |
| May 1, 2026 |  JNJ JOHNSON & JOHNSON | Tax Payment | 11,002 | $229.85 | $2,528,810 | Direct |
| May 1, 2026 | JNJ JOHNSON & JOHNSON | Exercise | 25,255 | - | $0 | Direct |
| Feb 17, 2026 | JNJ JOHNSON & JOHNSON | Sale | 21,721 | $243.00 | $5,278,203 | Direct |
| Feb 17, 2026 | JNJ JOHNSON & JOHNSON | Exercise | 21,721 | $157.92 | $3,430,180 | Direct |
| Feb 17, 2026 | JNJ JOHNSON & JOHNSON | Exercise | 29,927 | $156.15 | $4,673,101 | Direct |
| Feb 17, 2026 | JNJ JOHNSON & JOHNSON | Sale | 2,283 | $243.00 | $554,769 | Direct |
| Feb 17, 2026 | JNJ JOHNSON & JOHNSON | Sale | 29,927 | $243.00 | $7,272,261 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Exercise | 1,847 | - | $0 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment | 385 | $243.45 | $93,728 | Direct |
1-10 of 25 transactions